Abstract
Immunosuppressed organ allograft recipients are at risk of developing lymphomas and lymphoproliferative disorders as a consequence of immunosuppressive therapy and long-term antigenic stimulation from both the graft and possible viral infections. No more than 4% of the malignant tumors detected in organ recipients are plasmacytomas. Primary cutaneous plasmacytoma is a rare type of cutaneous B-cell lymphoma arising primarily in the skin. It is derived from clonally expanded plasma cells with various degrees of maturation and atypia. We report the occurrence of a solitary cutaneous plasmacytoma in a 56-year-old male patient undergoing hemodialysis after rejection of a grafted kidney. The diagnosis was made a few months after the kidney had been surgically removed. A thorough examination showed no evidence of systemic disease. Skin lesions were successfully treated with local radiotherapy. After 2 years of follow-up there were no local or systemic recurrences.
Similar content being viewed by others
References
Penn I. Some problems with posttransplant lymphoproliferative disease. Transplantation. 2000;69:705–706.
Fischer T, Miller M, Bott-Silverman C, Lichtin A. Posttransplant lymphoproliferative disease after cardiac transplantation. Transplantation. 1996;62:1687–1690.
Swerdlow AJ, Higgins CD, Hunt BJ, et al. Risk of lymphoid neoplasia after cardiothoracic transplantation. Transplantation. 2000; 69:897–904.
Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodg- kin’s disease. Lancet. 1991;337:320–322.
Tuting T, Bork K. Primary plasmacytoma of the skin. J Am Acad Dermatol. 1996;34:386–390.
Muscardin L, Pulsoni A, Cerroni L. Primary cutaneous plasmacytoma: report of a case with review of the literature. J Am Acad Dermatol. 2000;43:962–965.
Wong KF, Chan JKC, Li LPK, Yau TK. Primary cutaneous plasmacytoma: report of two cases and review of the literature. Am J Dermatopathol. 1994;16:392–397.
Kazakov DV, Belousova IE, Muller B, et al. Primary cutaneous plasmacytoma: a clinicopathological study of two cases with a longterm follow-up and review of the literature. J Cutan Pathol. 2002; 29:244–248.
Maisonneuve P, Agodoa L, Gellert R, et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet. 1999;354:93–99.
Bierkland SA, Lokkegaard H, Storm HH. Cancer in patients on dialysis and after renal transplantation. Lancet. 2000;355:1886–1887.
Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet. 1993;342:1514–1516.
Hanto DW, Simmons RI. Lymphoproliferative diseases in immuno-suppressed patients. In: Morris PJ, Tinley NL, eds. Progress in Transplantation. Edinburgh, UK: Churchill Livingstone; 1984:170–192.
Penn I. Letter to the editor. Am J Kidney Dis. 1988;11:201.
Penn I. Post-transplant malignancy: the role of immunosuppression. Drug Saf. 2000;23:101–112.
York LJ, Qualtiere LF. Cyclosporine abrogates virus-specific T cell control of EB V-induced B cell lymphoproliferation. Viral Immunol. 1990;3:127–136.
Zanazzi M, Bertoni E, Di Maria L, Rosati A, Tosi B, Salvadori M. Malignancies in renal transplant patients: etiopathogenetic, epidemiological and prevention aspects. Ital J Nephrol. 1999;16:564–575.
Dotti G, Fiocchi R, Motta T, et al. Epstein Barr virus-negative lymphoproliferative disorders in long-term survivors after heart, kidney and liver transplant. Transplantation. 2000;69:827–833.
Joseph G, Barker RL, Yuan B, Martin A, Medeiros J, Peiper SC. Post-transplantation plasma cell dyscrasias. Cancer. 1994;7:1959–1964.
Rees L, Amlot PL. Disappearance of an Epstein Barr virus-positive post-transplant plasmacytoma with reduction of immunosuppression. Lancet. 1998;352:789.
Nalesnik MA, Starzl TE. Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders. Transplant Sci. 1994;4:61–79.
Knowles DM. Immunodeficiency-associated lymphoproliferative disorders. Mol Pathol. 1999;12:200–217.
Leigh BR, Larkin EC, Scotte Doggett RL. Solitary extramedullary plasmacytoma five years after successful cardiac transplantation. Am J Clin Oncol. 1997;20:467–470.
Melato M, Paladini G. Multiple myeloma following reactivated Epstein Barr virus infection in a renal transplant recipient. Haematologica. 1986;71:241–243.
Whittam LR, Coleman R, MacDonald DM. Plasma cell tumour in a renal transplant recipient. Clin Exp Dermatol. 1996;21:367–369.
Aparicio M, De Precigout V, Reiffers J, et al. Multiple myeloma and AL amyloidosis in a renal transplant recipient. Nephron. 1989; 53:373–375.
Falkmer U, Jarhult J, Wersall P, Cavallin-Stahl E. A systematic overview of radiation therapy effects in skeletal metastases. Acta Oncol. 2003;42:620–633.
Gregory WM, Richards MA, Malpas JS. Combined chemotherapy versus melphalan and prednisolone for treatment of myelomatosis. Lancet. 1992;339:1353–1354.
Myeloma Trialists’ Collaborative Group. Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. J Clin Oncol. 1998;16:3832–3842.
Rosen LS, Gordon D, Kaminski M, et al. Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial. Cancer. 2003;15:1735–1744.
Rego F, Alcantara P, Buinho F, et al. Autologous peripheral stem cell transplantation for multiple myeloma in a patient with a 10 year-old kidney transplant: case report and clinical issues. Transplant Proc. 2003;35:1102–1104.
Stachel D, Schmid I, Lang T, Haas RJ, Otte JB. Double bone marrow transplantation for severe aplastic anemia after orthotopic liver transplantation: implications for clinical management and immune tolerance. Transpl Int. 2002;15:39–44.
Dey B, Sykes M, Spitzer TR. Outcomes of recipients of both bone marrow and solid organ transplants: a review. Medicine (Baltimore). 1998;77:355–369.
Perkins JL, Neglia JP, Ramsay NK, Davies SM. Successful bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation: long-term follow-up and outcome. Bone Marrow Transplant. 2001;28:523–526.
Mahe B, Moreau P, Le Tortorec S, Hourmant M, Harousseau JL, Milpied N. Autologous bone marrow transplantation for cyclosporin- related lymphoma in a renal transplant patient. Bone Marrow Transplant. 1994;14:645–646.
Au WY, Lie AKW, Chan EC, et al. Treatment of postrenal transplantation lymphoproliferative disease manifesting as plasmacytoma with nonmyeloablative hematopoietic stem cell transplantation from the same kidney donor. Am J Hematol. 2003;74:283–286.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Tessari, G., Fabbian, F., Colato, C. et al. Primary Cutaneous Plasmacytoma after Rejection of a Transplanted Kidney: Case Report and Review of the Literature. Int J Hematol 80, 361–364 (2004). https://doi.org/10.1532/IJH97.E0406
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1532/IJH97.E0406